PTH decreased cell apoptosis in a Flt-3L expanded population. by Flavia Q. Pirih (360515)

(A) CaMKII inhibition by KN-93 or AIP, or calmodulin inhibition by W-7 decreases O₂ consumption in SANC suspension (n = 5 for each drug), (B) AIP decreases mitochondrial flavoprotein fluorescence in single SANC (representative example), indicating a net reduction of flavoprotein pool. by Yael Yaniv (162548)

Thrombin-induced decreased lamellipodia protrusion frequency and actin stress fiber formation. by Jerome W. Breslin (548352)

“…<i>B</i>. Thrombin initially decreased the mean protrusion frequency of local lamellipodia. …”

The spectral sensitivity of European seabass fed a 5% taurine diet. by Richard W. Brill (2337940)

Cannabis smoke exposure decreases locomotor activity and rearing in the small open field. by Adriaan W. Bruijnzeel (2605954)

Decrease in the number of intestinal pDCs in <i>Enpp3</i>^<i>-/-</i> mice. by Yoki Furuta (3772735)

Cooperativity decreases with the expression level of CheA. by Stephan Eismann (835052)

Frequency distribution of the hourly ERA5 reanalysis vs observations illustrating the best score (a: W02 station and b: W11 station) and the poorest score (c: W18 station and b: W1... by Weidong Ji (129916)

S5 Fig - by Jordan K. Abbott (8934239)

Variability is correlated with increasing repeat length, increasing purity, and decreasing unit size. by John W. Fondon III (145820)

Mutation of Ser-473 in GC-A to alanine but not glutamate decreases ANP-stimulated guanylyl cyclase activity. by Andrea R. Yoder (165684)

Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

Early increase and later decrease in GSK-3β activity. by Arie J. Hoogendijk (353624)

Conventional dynamic latch comparator [13], [14]. by Labonnah Farzana Rahman (641767)

Subjects:

Performance comparison of the proposed dynamic latch comparator. by Labonnah Farzana Rahman (641767)

Subjects:

Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

Subjects:

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

Subjects:

Study Flow Diagram. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

Subjects: